ENTA Conducting Clinical Trial of Investigational Regenerative Medication to Restore Hearing Function in Sensorineural Hearing Loss (SNHL) Patients Tarrytown, New York, March 11, 2022 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA), the largest ear, nose, throat, allergy, and audiology practice in the nation, which continuously...